In the media 26 Jun 2024 Framework to help curb visceral leishmaniasis in East Africa Health Policy Watch
In the media 25 Jun 2024 Consider This: Dengue vaccine (part 3) — Pandemic lessons: Prevent vaccine inequity Astro Awani
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
In the media 22 Jun 2024 What role does capacity development play in transforming health research? Health Policy Watch
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Press releases 21 Jul 2008 Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices
Press releases 21 Jul 2008 Chagas Disease Partnership Will Deliver Safe, Easy-to-Use Treatment for Children
Press releases 26 Jun 2008 DNDi calls on G8 leaders to increase their commitment to neglected tropical diseases
Press releases 23 Jun 2008 DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs
Press releases 4 Jun 2008 The University of North Carolina and DNDi Agree to Synergize Novel R&D Efforts to Develop Drugs for the Most Neglected
Press releases 8 May 2008 DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected
Press releases 17 Apr 2008 A Worldwide Public Partnership Makes Available a New, Once-a-Day Fixed-Dose Combination against Malaria
Press releases 6 Mar 2008 GlaxoSmithKline, Drugs for Neglected Diseases initiative to Collaborate on Research Projects to Meet Public Health Needs in the Developing World
Press releases 6 Mar 2008 Spanish government commits EUR 5 million to DNDi’s research for new medicines for neglected diseases
Press releases 12 Dec 2007 DNDi Receives $25.7M from the Bill & Melinda Gates Foundation to Develop New Medicines for Neglected Diseases
Press releases 5 Nov 2007 The US National Institutes of Health Awards DNDi with a 3-Year Grant Dedicated to the Development of a Low-Cost Treatment for Visceral Leishmaniasis
Press releases 1 Nov 2007 SCYNEXIS and DNDi Enter Landmark Multi-Year Agreement to Identify Drug Candidates to Treat Sleeping Sickness
Press releases 12 Oct 2007 DNDi Executive Team Adds Two New Directors, Including Former Abbott VP Shing Chang as New R&D Director
Press releases 11 Oct 2007 Advinus Therapeutics and DNDi Join Forces on Drug Discovery and Development for Visceral Leishmanias (Kala Azar)
Press releases 13 Jul 2007 DNDi Welcomes Marcel Tanner As Chair of the Board of Directors Along With New Chair of the Scientific Advisory Committee